Product News
Overcome the major challenges in gene therapy with PROGEN's portfolio of AAV antibodies
PROGEN´s unique portfolio of AAV antibodies allows process monitoring and quality control of the complete value chain
PROGEN´s unique portfolio of AAV antibodies allows process monitoring and quality control of the complete value chain
The AAV lateral flow tests represent a quick in-process control suitable for crude lysate as well as purified AAV analysis within less than 20 minutes
The kits have been developed based on the traditional PROGEN ELISA kits which have already earned reference standard status in gene therapy centers worldwide